3-D high-resolution mapping of the heterogeneity in mitochondrial redox state of human breast tumor xenografts

Advances in Experimental Medicine and Biology

Volumn 737, Issue , 2012, Pages 169-174

  Xu, H N ^a   Nioka, S ^a   Chance, B ^a   Li, L Z ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST TUMOR; CANCER CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MITOCHONDRIAL REDOX STATE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; THREE DIMENSIONAL IMAGING; TUMOR XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; MICE; MITOCHONDRIA; NEOPLASM TRANSPLANTATION; OXIDATION-REDUCTION; OXYGEN; TRANSPLANTATION, HETEROLOGOUS;

MUS; MUS MUSCULUS;

EID: 84863079490     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-1566-4_25     Document Type: Article

References (17)

1. Heppner GH, Miller FR (1998) The cellular basis of tumor progression. Int Rev Cytol 177:1-56
2. Heppner GH (1984) Tumor heterogeneity. Cancer Res 44:2259-2265
3. Allred DC, Wu Y, Mao S et al (2008) Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution. Clin Cancer Res 14:370-378
4. Park SY, Lee HE, Li H et al (2010) Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 16:876-887
5. Vaupel P, Hockel M, Mayer A (2007) Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal 9:1221-1235
6. Vaupel P, Schlenger K, Knoop C et al (1991) Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O 2 tension measurements. Cancer Res 51:3316-3322
7. Li LZ, Zhou R, Xu HN et al (2009) Quantitative magnetic resonance and optical imaging biomarkers of melanoma metastatic potential. Proc Natl Acad Sci U S A 106:6608-6613
8. Xu HN, Nioka S, Glickson JD et al (2010) Quantitative mitochondrial redox imaging of breast cancer metastatic potential. J Biomed Opt 15:036010
9. Xu HN, Wu B, Nioka S et al (2009) Calibration of redox scanning for tissue samples. Proceedings of Biomedical Optics in San Jose, CA, Jan. 24, Ed. SPIE 7174:71742F
10. Chance B, Schoener B, Oshino R et al (1979) Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples NADH and fl avoprotein fl uorescence signals. J Biol Chem 254:4764-4771
11. Gu Y, Qian Z, Chen J et al (2002) High-resolution three-dimensional scanning optical image system for intrinsic and extrinsic contrast agents in tissue. Rev Sci Instrum 73:172-178
12. Li LZ, Xu HN, Ranji M et al (2009) Mitochondrial redox imaging for cancer diagnostic and therapeutic studies. J Innov Opt Health Sci 2:325-341
13. Köster F, Engel J, Schally A et al (2009) Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition. Breast Cancer Res Treat 116:273
14. Bartholomeusz C, Gonzalez-Angulo AM, Kazansky A et al (2010) PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin Cancer Res 16:1802-1811
15. Anders C, Carey LA (2008) Understanding and treating triple-negative breast cancer. Oncology (Williston Park) 22:1233-1239, discussion 1239-40, 1243
16. Freund A, Chauveau C, Brouillet JP et al (2003) IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene 22:256-265
17. Thompson EW, Paik S, Brunner N et al (1992) Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines. J Cell Physiol 150:534-544